[1] Engels EA, Pfeiffer RM.Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies[J]. Int J Cancer, 2003, 105(4):546-551. [2] Wright CD.Management of thymomas[J]. Oncol Hematol, 2008, 65(2):109-120. [3] 张桥. 卫生毒理学基础 [M]. 北京: 人民卫生出版社, 2000.140-150. [4] 黄榕芳, 余英豪. N-甲基亚硝基脲在动物肿瘤模型研究中的应用现状[J]. 中国误诊学杂志, 2008, 8(4):774-777. [5] 黄榕芳, 余英豪. 鼠恶性淋巴瘤动物模型研究现状[J]. 中国误诊学杂志, 2007, 7(17):3958-3960. [6] Benavides F, Gomez G, Venables GA, et al.Differential susceptibility to chemically induced thymic lymphomas in SENCARB and SSIN inbred mice[J]. Mol Carcinog, 2006, 45(7):543-548. [7] 黄榕芳, 余英豪, 吴在增. 小鼠胸腺淋巴瘤动物模型的建立[J]. 中国实验血液学杂志, 2009, 17(5):1220-1223. [8] Qin X, Liu L, Gerson SL.Mice defective in the DNA mismatch gene PMS2 are hypersensitive to MNU induced thymic lymphoma and are partially protected by transgenic expression of human MGMT. Onco-gene, 1999; 18(30):4394-4400. [9] Kang HM, Jang JJ, Langford C, et al.DNA copy number alterations and expression of relevant genes in mouse thymic lymphomas induced by gamma irradiation and N-methyl-N-nitrosourea[J]. Cancer Genet Cyto genet, 2006, 166(1):27-35. [10] Elisabeth Z, Nancy WA, Mark DW, et al.Injection of human primary effusion lymphoma cells or associated macrophages in severe combined immunod efficient mice causes murine lymphoma[J]. Cancer Res,2002;62:5536-5542. [11] Todd S C, Tsoukas CD.EBV induces proliferation of immature human thymocytes in an IL-2-mediated response[J]. Immunol, 1996, 156:4217-4223. [12] Kearns-Jonker M, Monell-Torrens E, Abbasi F, et al.EBV binds to lymphocytes of transgenic mice that express the human CR2 gene[J]. Virus Res, 1997, 50(1):85-94. [13] Jones J F, Shurin S, Abramowsky C, et al.T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infection[J]. N Engl J Med, 1988, 318:733. [14] Mingxu G, Gaetano R, Earl EH.Epstein-Barr virus(EBV) induced long-term proliferation of CD+4lymphocytes leading to T lymphoblastoid cell lines carrying EBV[J]. Anticancer Res,1999,19:3007-3018. [15] Yin ZH, Liu TF, Tang YL, et al.Effect of cyclosporine on stable established lymphoma models induced by Epstein-Baarr virus[J]. Chinese Journal of Immunology, 2002, 18(11): 760-763. [16] Gan R, Yin Z, Liu T, et al.Cyclosporine A effectively inhibits graft-versus-host disease during development of Epstein-Barr virus-infected human B cell lymphoma in SCID mouse[J]. Cancer Sci, 2003, 94(9):796-801. [17] 甘润良, 尹志华, 刘腾飞, 等. EB病毒诱发人B细胞淋巴瘤的分子病理特性[J]. 生物化学与生物物理学报, 2003, 35:925-929. [18] 张彦, 冯哲玲, 熊建军, 等. EB病毒相关淋巴瘤动物模型的建立以及肿瘤治疗的初步探讨[J]. 现代医学仪器与应用, 2008, 20(1):8-12. [19] Popescu I, Macedo C, Zeevi A, et al.Ex vivo priming of naive T cells into EBV-specific Th1/Tc1 effector cells by mature autologous DC loaded with apoptotic/necrotic LCL[J].Am J Transplant, 2003, 3(11):1369-1377. [20] Watry D, Hedrick J A, Siervo S.et al.Infection of human thymocytes by Epstein-Barr virus[J]. J Exp Med, 1991, 173(4):971-980. [21] Nanbo A, Takada K.The role of Epstein-Barr virus-encoded small RNAs (EBERs) in oncogenesis. RevMed Virol, 2002, 12(5):321-326. [22] Jooryung H, Kwanghyun C, Dae Seog H, et al.Detection of Epstein-Barr virus in Korean peripheral T-cell lymphoma[J]. Am J Hematol,1999,60:205-214. [23] Baichwal VR, Sugden B.Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus[J]. Oncogene, 1988,2:461-467. [24] Kulwichit W, Edwards RH, Davenport EM, et al.Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice[J]. Proc Natl Acad Sci USA, 1998, 95:11963-11968. [25] Izumi KM, Kieff E.The Epstein-Barr virus oncogene product latent membrane protein engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-Kb[J]. Proc Natl Acad Sci USA, 1997, 94:12592-12597. [26] 黄燕萍, 郭秀婵, 何祖根, 等. EB病毒诱导胸腺恶性T细胞淋巴瘤的研究[J]. 病毒学报, 2001, 17(4):289-294. [27] Strockbine LD, Cohen JI, Farrah T, et al.The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor[J]. J Virol, 1998, 72:4015-4021 [28] Kaplan HS, Brown MB, Paull J.Influence of bone marrow injections on involution and neoplasia of mouse thymus after systemic irradiation[J]. J Natl Cancer Inst, 1953, 14(2): 303-316. [29] De Bernardis F, Liu H, O’Mahony R, et al. Human domain antibodies against virulence traits of Candida albicans inhibit fungus adherence to vaginal epithelium and protect against experimental vaginal candidiasis[J]. J Infect Dis, 2007, 195(1):149-157. [30] Utsuyama M, Hirokawa K.Radiation-induced-thymic lymphoma occurs in young, but not in old mice[J]. Exp Mol Pathol, 2003, 74(3):319-325. [31] Ishii-Ohba H, Kobayashi S, Nishimura M, et al.Existence of a threshold-like dose for gamma-ray induction of thymic lymphomas and no susceptibility to radiation-induced solid tumors in SCID mice[J]. Mutat Res, 2007, 619(1-2):124-133. [32] 李秀娟, 赫荣华, 李修义, 等. 低剂量辐射适应性反应对辐射诱发小鼠胸腺淋巴瘤的影响[J]. 中华放射医学与防护杂志, 2000, 20(3):153-156. [33] Kominaml R, Niwa O.Radiation carcinogenesis in mouse thymic lymphomas[J]. Cancer Sci, 2006, 97(7):575-581. [34] Dange P, Sarma H, Pandey BN, et al.Radiation-induced incidence of thymic lymphoma in mice and its prevention by antioxidants[J]. J Environ Pathol Toxicol Oncol, 2007, 26(4):273-279. [35] Nishimura M.Low frequency of Ras gene mutation in spontaneous and gamma-ray-induced thymic lymphomas of scid mice[J]. Radiat Res, 1999, 151:142-151. [36] 于雷, 刘永哲, 孙世龙, 等. c-myc和k-ras基因多态性与辐射诱发小鼠胸腺淋巴瘤的关联性分析. 吉林大学学报 (医学版), 2009, 35(2):296-300. [37] Santos J, Gonzalez-sanchez L, Matabuena-deyzaguirre M, et al. A role for stroma-derived annexin A1 as mediator in the control of genetic susceptibility to T-cell lymphoblastic malignancies through prostaglandin E2 secretion[J]. Cancer Res, 2009, 69(6):2577-2587. |